Literature DB >> 25063364

Foxp3 expression in T regulatory cells and other cell lineages.

Christel Devaud1, Phillip K Darcy, Michael H Kershaw.   

Abstract

Forkhead box P3 (Foxp3) is an important transcription factor that belongs to the forkhead/winged-helix family of transcriptional regulators. Foxp3 has been extensively studied over the past 13 years as a master regulator of transcription in a specific T-cell type, CD4(+) regulatory T cells (Treg), both in humans and in mice. Compelling data characterize Foxp3 as critically important and necessary for the development and the differentiation of Treg. It has been considered initially as the only specific marker for Treg. However, recent work has proposed that Foxp3 can be expressed by other types of lymphoid cells or myeloid cells and also by some non-hematopoietic cells such as epithelial cells. It remains controversial about the expression of Foxp3 in cells other than Treg, but understanding the potential expression and function of this master regulator in different cell subsets could have a wide range of implications for immune tolerance and several pathologies including autoimmune disorders and immune responses to cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25063364     DOI: 10.1007/s00262-014-1581-4

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  33 in total

1.  Hepatitis B Virus Core Particles Containing a Conserved Region of the G Protein Combined with Interleukin-35 Protected Mice against Respiratory Syncytial Virus Infection without Vaccine-Enhanced Immunopathology.

Authors:  Jie Yang; Chen Ma; Yu Zhao; Anjing Fan; Xiufen Zou; Zishu Pan
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 2.  FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity.

Authors:  Theresa L Whiteside
Journal:  Expert Opin Ther Targets       Date:  2018-04-10       Impact factor: 6.902

Review 3.  Human Immune Monitoring Techniques during Food Allergen Immunotherapy.

Authors:  Blake J Rust; Erik Wambre
Journal:  Curr Allergy Asthma Rep       Date:  2017-04       Impact factor: 4.806

4.  Proinflammatory cytokine interferon-γ and microbiome-derived metabolites dictate epigenetic switch between forkhead box protein 3 isoforms in coeliac disease.

Authors:  G Serena; S Yan; S Camhi; S Patel; R S Lima; A Sapone; M M Leonard; R Mukherjee; B J Nath; K M Lammers; A Fasano
Journal:  Clin Exp Immunol       Date:  2017-01-12       Impact factor: 4.330

5.  CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer.

Authors:  Fee Bengsch; Dawson M Knoblock; Anni Liu; Florencia McAllister; Gregory L Beatty
Journal:  Cancer Immunol Immunother       Date:  2017-08-30       Impact factor: 6.968

6.  Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis.

Authors:  Michael C Jensen; Julie R Park; Nicholas A Vitanza; Adam J Johnson; Ashley L Wilson; Christopher Brown; Jason K Yokoyama; Annette Künkele; Cindy A Chang; Stephanie Rawlings-Rhea; Wenjun Huang; Kristy Seidel; Catherine M Albert; Navin Pinto; Juliane Gust; Laura S Finn; Jeffrey G Ojemann; Jason Wright; Rimas J Orentas; Michael Baldwin; Rebecca A Gardner
Journal:  Nat Med       Date:  2021-07-12       Impact factor: 53.440

7.  The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.

Authors:  Satu Salmi; Anton Lin; Benjamin Hirschovits-Gerz; Mari Valkonen; Niina Aaltonen; Reijo Sironen; Hanna Siiskonen; Sanna Pasonen-Seppänen
Journal:  BMC Cancer       Date:  2021-05-29       Impact factor: 4.430

8.  Sevoflurane represses the migration and invasion of gastric cancer cells by regulating forkhead box protein 3.

Authors:  Fangfang Yong; Hemei Wang; Chao Li; Huiqun Jia
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

9.  Human regulatory T cells (Treg) and their response to cancer.

Authors:  Theresa L Whiteside
Journal:  Expert Rev Precis Med Drug Dev       Date:  2019-07-15

10.  ASSOCIATION OF FOXP3 GENE VARIANTS WITH RISK OF HASHIMOTO'S THYROIDITIS AND CORRELATION WITH ANTI-TPO ANTIBODY LEVELS.

Authors:  K Kalantar; S Khansalar; M Eshkevar Vakili; D Ghasemi; M H Dabbaghmanesh; Z Amirghofran
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Oct-Dec       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.